argenx to Report Half Year 2025 Financial Results and Second Quarter Business Update on July 31, 2025
argenx (Euronext & Nasdaq: ARGX), a global immunology company, will host a conference call and audio webcast on Thursday, July 31, 2025 at 2:30 p.m. CET (8:30 a.m. ET) to discuss its half year 2025 financial results and second quarter business update.
The webcast will be accessible through the Investors section of the argenx website at argenx.com/investors, with a replay available for approximately one year. The company has provided international dial-in numbers and the access code 3810049 for participants, who are advised to dial in 15 minutes before the call.
argenx (Euronext e Nasdaq: ARGX), un'azienda globale nel settore dell'immunologia, terr脿 una conference call e una trasmissione audio in diretta il gioved矛 31 luglio 2025 alle 14:30 CET (8:30 ET) per discutere i risultati finanziari del primo semestre 2025 e l'aggiornamento sulle attivit脿 del secondo trimestre.
La diretta sar脿 accessibile nella sezione Investitori del sito argenx all'indirizzo argenx.com/investors, con una replica disponibile per circa un anno. L'azienda ha fornito numeri internazionali per la chiamata e il codice di accesso 3810049 per i partecipanti, che sono invitati a collegarsi 15 minuti prima dell'inizio della call.
argenx (Euronext y Nasdaq: ARGX), una empresa global de inmunolog铆a, llevar谩 a cabo una conferencia telef贸nica y una transmisi贸n de audio en vivo el jueves 31 de julio de 2025 a las 14:30 CET (8:30 a.m. ET) para analizar los resultados financieros del primer semestre de 2025 y la actualizaci贸n del negocio del segundo trimestre.
La transmisi贸n estar谩 disponible en la secci贸n de Inversores del sitio web argenx en argenx.com/investors, con una repetici贸n accesible durante aproximadamente un a帽o. La empresa ha proporcionado n煤meros internacionales para marcar y el c贸digo de acceso 3810049 para los participantes, quienes se recomienda que llamen 15 minutos antes de la conferencia.
argenx (鞙犽雱レ姢韸� 氚� 雮橃姢雼�: ARGX)電� 旮�搿滊矊 氅挫棴頃� 旮办梾鞙茧靹� 2025雲� 7鞗� 31鞚� 氇╈殧鞚� 鞓ろ泟 2鞁� 30攵� CET (氙戈淡 霃欕秬 鞁滉皠 鞓れ爠 8鞁� 30攵�)鞐� 2025雲� 靸侂皹旮� 鞛 鞁れ爜 氚� 2攵勱赴 靷梾 鞐呺嵃鞚错姼毳� 雲检潣頃橁赴 鞙勴暅 旎嵓霟办姢 旖� 氚� 鞓る敂鞓� 鞗轨簮鞀ろ姼毳� 臧滌禍頃╇媹雼�.
鞗轨簮鞀ろ姼電� argenx 鞗轨偓鞚错姼鞚� 韴瀽鞛� 靹轨厴 argenx.com/investors毳� 韱淀暣 鞝戩啀頃� 靾� 鞛堨溂氅�, 鞎� 1雲勱皠 雼れ嫓氤搓赴 靹滊箘鞀り皜 鞝滉车霅╇媹雼�. 須岇偓電� 甑牅 鞝勴檾 鞝戩啀 氩堩樃鞕� 彀戈皜鞛愳毄 鞝戩啀 旖旊摐 3810049毳� 鞝滉车頃橂┌, 彀戈皜鞛愲摛鞚� 旖� 鞁滌瀾 15攵� 鞝勳棎 鞝戩啀頃� 瓴冹潉 甓岇灔頃╇媹雼�.
argenx (Euronext et Nasdaq : ARGX), une entreprise mondiale en immunologie, organisera une conf茅rence t茅l茅phonique et une diffusion audio en direct le jeudi 31 juillet 2025 脿 14h30 CET (8h30 ET) pour discuter des r茅sultats financiers du premier semestre 2025 et de la mise 脿 jour commerciale du deuxi猫me trimestre.
La diffusion sera accessible via la section Investisseurs du site argenx 脿 l'adresse argenx.com/investors, avec un replay disponible pendant environ un an. L'entreprise a fourni des num茅ros d'acc猫s internationaux ainsi que le code d'acc猫s 3810049 pour les participants, qui sont invit茅s 脿 se connecter 15 minutes avant le d茅but de l'appel.
argenx (Euronext & Nasdaq: ARGX), ein globales Immunologie-Unternehmen, wird am Donnerstag, den 31. Juli 2025 um 14:30 Uhr CET (8:30 Uhr ET) eine Telefonkonferenz und einen Audio-Webcast veranstalten, um die Finanzergebnisse f眉r das erste Halbjahr 2025 sowie ein Update zum Gesch盲ft im zweiten Quartal zu besprechen.
Der Webcast ist 眉ber den Investor-Bereich auf der argenx-Website unter argenx.com/investors zug盲nglich, wobei eine Wiederholung f眉r etwa ein Jahr verf眉gbar sein wird. Das Unternehmen stellt internationale Einwahlnummern sowie den Zugangscode 3810049 f眉r Teilnehmer bereit, die empfohlen werden, 15 Minuten vor Beginn der Konferenz einzuw盲hlen.
- None.
- None.
July 24, 2025
Amsterdam, the Netherlands 鈥� argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, July 31, 2025 at 2:30 p.m. CET (8:30 a.m. ET) to discuss its half year 2025 financial results and provide a second quarter business update.
A webcast of the live call may be accessed on the Investors section of the argenx website at . A replay of the webcast will be available on the argenx website for approximately one year following the presentation.
Dial-in numbers:
Belgium聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽32 800 50 201
France聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽33 800 943355
Netherlands聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽31 20 795 1090
United Kingdom聽聽聽聽聽聽聽聽44 800 358 0970
United States聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽1 888 415 4250
Japan聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽81 3 4578 9081
Switzerland聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽41 43 210 11 32
Use the access code 3810049 to join the call. Please dial in 15 minutes prior to the live call.
About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit聽聽and follow us on聽,听,听, and聽.
Contacts
Media:
Ben Petok
Investors:
Alexandra Roy
FAQ
When will argenx (ARGX) report its half year 2025 financial results?
How can investors access argenx's (ARGX) half year 2025 earnings call?
Will argenx's (ARGX) earnings call webcast be available for replay?
What is the access code for argenx's (ARGX) half year 2025 earnings call?
